Oleg V. Markov - Publications

Deciphering Pathogenesis of Silica Nanoparticle-Induced Airway Remodeling and Fibrosis: Insights from a Human Patient Cohort and a Murine Model.

Journal: Nanomaterials (Basel, Switzerland)

Published: June 17, 2026

Targeted Inhibition of Oncogenic microRNAs miR-21, miR-17, and miR-155 Suppresses Tumor Growth and Modulates Immune Response in Colorectal Cancer.

Journal: Pharmaceutics

Published: November 07, 2025

Cyclophosphamide-Mediated Induction of Myeloid-Derived Suppressor Cells In Vivo: Kinetics of Accumulation, Immune Profile, and Immunomodulation by Oleanane-Type Triterpenoids.

Journal: International journal of molecular sciences

Published: October 24, 2025

Tuning the in vivo transfection efficiency of mRNA-Loaded lipoplexes by PEG-Lipid structure and ratio.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: August 20, 2025

Novel Cross-Cancer Hub Genes in Doxorubicin Resistance Identified by Transcriptional Mapping.

Journal: Biomedicines

Published: August 18, 2025

Two paired HPV-59 cervical cancer cell lines with distinct chemoradioresistant phenotypes.

Journal: Scientific reports

Published: July 02, 2025

Neutrophils in Cancer: Phenotypic Heterogeneity Across Tumor Models and Significant Alteration of Splenic Neutrophil Phenotype in Lymphosarcoma RLS40 Model Following DNase I Treatment.

Journal: Cancers

Published: July 01, 2025

A new combination of 5'- and 3'-untranslated regions increases the expression of mRNAs in vitro and in vivo.

Journal: Vavilovskii zhurnal genetiki i selektsii

Published: February 11, 2025

The impact of cytokines and tumour-conditioned medium on the properties of murine in vitro generated myeloid-derived suppressor cells.

Journal: Scandinavian journal of immunology

Published: August 19, 2024

Extracellular vesicle mimetics as delivery vehicles for oligonucleotide-based therapeutics and plasmid DNA.

Journal: Frontiers in bioengineering and biotechnology

Published: May 24, 2024

Soloxolone para-methylanilide effectively suppresses aggressive phenotype of glioblastoma cells including TGF-β1-induced glial-mesenchymal transition in vitro and inhibits growth of U87 glioblastoma xenografts in mice.

Journal: Frontiers in pharmacology

Published: May 07, 2024

Novel Efficient Lipid-Based Delivery Systems Enable a Delayed Uptake and Sustained Expression of mRNA in Human Cells and Mouse Tissues.

Journal: Pharmaceutics

Published: April 18, 2024